Per research from the Blue Cross Blue Shield Association, nearly 6 in 10 will discontinue a GLP-1 before reaching a clinically meaningful health benefit
Hgy P, Brunnbauer M, Koehler P, Schwadorf K, Breuer J, Franzaring J, Zhunusbayeva D, Fangmeier A (2013) Grain quality characteristics of spring wheat (Triticum aestivum) as affected by free-air CO 2 enrichment
Leaky gut as a danger signal for autoimmune diseases
For best results, pair with Pure PC for overall cellular health
Gastrointestinal: Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death, ileus General Disorders and Administration Site Conditions: Allergic reactions: rash and pruritus Hepatobiliary: Elevations of liver enzymes, hyperbilirubinemia, cholestasis, cholecystitis, cholelithiasis requiring cholecystectomy, hepatitis Immune system: Angioedema and anaphylactic reactions Metabolism and nutrition: Dehydration resulting from nausea, vomiting and diarrhea Neoplasms: Medullary thyroid carcinoma Nervous system: Dysgeusia, dizziness Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation